|4Jul 12, 4:47 PM ET

CATALYST BIOSCIENCES, INC. 4

4 · CATALYST BIOSCIENCES, INC. · Filed Jul 12, 2017

Insider Transaction Report

Form 4
Period: 2017-07-11
Payne Fletcher
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-07-11+75,00075,000 total
    Exercise: $4.63Exp: 2027-07-11Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The Option vests monthly over a period of four years commencing June 15, 2017.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION